The Environmental Enteric Dysfunction Biopsy Initiative (EEDBI) Consortium: mucosal investigations of environmental enteric dysfunction
Denno DM., Ahmed S., Ahmed T., Ali SA., Amadi B., Kelly P., Lawrence S., Mahfuz M., Marie C., Moore SR., Nataro JP., Petri WA., Sullivan PB., Tarr PI., Ahmed K., Alam MA., Barnes BH., Begum SKN., Borowitz SM., Chandwe K., Chipunza M., Das S., Denson LA., Donowitz JR., Fahim SM., Gazi MA., Gilchrist CA., Haque R., Hasan MM., Hossain MS., Hotwani A., Iqbal J., Iqbal NT., Jakhro S., Kabir F., Mann BJ., Mazumder RN., Memon W., Middleton JP., Nayak U., Oliphant S., Qureshi AK., Rahman M., Rahman N., Ramakrishnan G., Sadiq K., Sarker SA., Umrani F.
Environmental enteric dysfunction (EED) is an asymptomatic acquired disorder characterized by upper small bowel inflammation, villus blunting, and gut permeability. It is a major contributor to poor growth in childhood as well as other highly consequential outcomes such as delayed neuorcognitive development. After decades of intermittent interest in this entity, we are now seeing a resurgence in the field of EED. However, recent studies have been hampered by a lack of investigation of the target tissue—the upper small bowel. In 2016, the EEDBI (Environmental Enteric Dysfunction Biopsy Initiative) Consortium was established as a common scientific platform across 3 independent EED biopsy cohort studies in Bangladesh, Pakistan, and Zambia. Two centers in the United States recruited comparison groups of children undergoing endoscopy for clinical indications. The EEDBI Consortium goal was to augment the contributions of the individual centers and answer high-level questions amenable to analysis and interpretation across the studies. Here, we describe the Consortium and its cohorts and recruitment procedures across studies. We also offer details applicable to all papers in this supplement, which describe EED mucosal histology, morphometry, immunohistochemistry, and transcriptomics as well as histology relationship to pathogens and biomarkers.